Delivery Order SPE2DB20D1100-SPE2DB25FE2M8
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Visipaque 320 mg/ml in 100-milliliter bottles, valued at $1,335.12. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by August 21, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,296.38 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $2,002.68, for Visipaque 320 mg/ml in a 100 ml bottle. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, issued on July 29, 2025. The award is non-competitive set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $32,271.62 by the Medical Supply Chain, a component of the Department of Defense, for the supply of Visipaque 320 mg/ml in 100 ml bottles. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and represents a non-set-aside procurement. The contract was executed on August 13, 2025, with performance to take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $3,004.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL, a contrast agent used in medical imaging procedures. This award, made on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a child order under a larger contract vehicle. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,687.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VISIPAQUE 320 MG/ML INFUS BTL 150ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The award has a potential value of $4,219.10 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this contract. This delivery order is issued under an indefinite delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Visipaque 320 mg/ml, a pharmaceutical product, with a ceiling value of $26,715.17 and a period of performance through July 3, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.56 contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and is a firm fixed price delivery order with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...